User menu

Factors associated with presentation to care with advanced HIV disease in Brussels and Northern France: 1997-2007

Bibliographic reference Ndiaye, Bakhao ; Salleron, Julia ; Vincent, Anne ; Bataille, Pierre ; Bonnevie, Frédérique ; et. al. Factors associated with presentation to care with advanced HIV disease in Brussels and Northern France: 1997-2007. In: BMC infectious diseases, Vol. 11, no.1, p. 11 (2011)
Permanent URL
  1. Girardi Enrico, Sabin Caroline A, Monforte Antonella d??Arminio, Late Diagnosis of HIV Infection: Epidemiological Features, Consequences and Strategies to Encourage Earlier Testing : , 10.1097/01.qai.0000286597.57066.2b
  2. Lanoy E, Mary-Krause M, Tattevin P, Perbost I, Poizot-Martin I, Dupont C, Costagliola D: Frequency, determinants and consequences of delayed access to care for HIV infection in France. Antivir Ther. 2007, 12: 89-96.
  3. Wolbers M, Bucher HC, Furrer H, Rickenbach M, Cavassini M, Weber R, Schmid P, Bernasconi E, Hirschel B, Battegay M, , Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study, 10.1111/j.1468-1293.2008.00566.x
  4. Borghi Vanni, Girardi Enrico, Bellelli Stefania, Angeletti Claudio, Mussini Cristina, Porter Kholoud, Esposito Roberto, Late Presenters in an HIV Surveillance System in Italy During the Period 1992-2006 : , 10.1097/qai.0b013e318186eabc
  5. Manavi K, McMillan A, Ogilvie M, Scott G, Heterosexual men and women with HIV test positive at a later stage of infection than homo- or bisexual men, 10.1258/0956462042563585
  6. Sullivan A. K, Newly diagnosed HIV infections: review in UK and Ireland, 10.1136/bmj.38398.590602.e0
  7. UK Collaborative HIV Cohort (UK CHIC) Steering Committee: Late diagnosis in the HAART era: proposed common definitions and associations with mortality. AIDS. 2010, 24: 723-727.
  8. Chadborn Timothy R, Baster Kathleen, Delpech Valerie C, Sabin Caroline A, Sinka Katy, Rice Brian D, Evans Barry G, No time to wait: how many HIV-infected homosexual men are diagnosed late and consequently die? (England and Wales, 1993–2002) : , 10.1097/01.aids.0000162340.43310.08
  9. Egger Matthias, May Margaret, Chêne Geneviève, Phillips Andrew N, Ledergerber Bruno, Dabis François, Costagliola Dominique, Monforte Antonella D'Arminio, de Wolf Frank, Reiss Peter, Lundgren Jens D, Justice Amy C, Staszewski Schlomo, Leport Catherine, Hogg Robert S, Sabin Caroline A, Gill M John, Salzberger Bernd, Sterne Jonathan AC, Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies, 10.1016/s0140-6736(02)09411-4
  10. Sterling Timothy R., Chaisson Richard E., Moore Richard D., HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy : , 10.1097/00002030-200111230-00006
  11. Castilla Jesús, Sobrino Paz, de la Fuente Luis, Noguer Isabel, Guerra Luis, Parras Francisco, Late diagnosis of HIV infection in the era of highly active antiretroviral therapy : consequences for AIDS incidence, 10.1097/00002030-200209270-00012
  12. Sterling Timothy R., Chaisson Richard E., Keruly Jeanne, Moore Richard D., Improved Outcomes with Earlier Initiation of Highly Active Antiretroviral Therapy Among Human Immunodeficiency Virus–Infected Patients Who Achieve Durable Virologic Suppression: Longer Follow‐Up of an Observational Cohort Study, 10.1086/379741
  13. Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, Monforte A d'Arminio, Yust I, Bruun JN, Phillips AN, Lundgren JD, Changing patterns of mortality across Europe in patients infected with HIV-1, 10.1016/s0140-6736(98)03201-2
  14. Weinhardt L S, Carey M P, Johnson B T, Bickham N L, Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997., 10.2105/ajph.89.9.1397
  15. The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals, 10.2105/ajph.91.7.1019
  16. Krentz HB, Auld MC, Gill MJ, The high cost of medical care for patients who present late (CD4<200 cells/muL) with HIV infection, 10.1111/j.1468-1293.2004.00193.x
  17. Donnell Deborah, Baeten Jared M, Kiarie James, Thomas Katherine K, Stevens Wendy, Cohen Craig R, McIntyre James, Lingappa Jairam R, Celum Connie, Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis, 10.1016/s0140-6736(10)60705-2
  18. Wood E., Kerr T., Marshall B. D L, Li K., Zhang R., Hogg R. S, Harrigan P R., Montaner J. S G, Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study, 10.1136/bmj.b1649
  19. InVS données au 30/06/2008. [ ]
  20. Sas A, Defraye A, Buziarsist J: Epidémiologie du SIDA et de l'infection à VIH en Belgique-Situation au 31 décembre 2007. 2008, Institut Scientifique de Santé Publique, Bruxelles, ISSN: D/2008/2505/54
  21. Yazdanpanah Yazdan, Chêne Geneviève, Losina Elena, Goldie Sue J, Merchadou Laurence Dequae, Alfandari Serge, Seage George R, Sullivan Lisa, Marimoutou Catherine, Paltiel A David, Salamon Roger, Mouton Yves, Freedberg Kenneth A, Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts, 10.1093/ije/30.4.864
  22. Service des maladies infectieuses, Université catholique de Louvain. [ ]
  23. Ancelle-Park Rosemary, Klein J.P., Stroobant A., Smith E., Haikala O., Koch M.A., Papaevangelou G., Walsh J., Rezza G., Krau P.Huberty, Coutinho R., Paixão M.T., de Andres Medina R., Bottiger M., Estermann J., Gill N., Brunet J.B., Expanded European AIDS case definition, 10.1016/0140-6736(93)93040-8
  24. Girardi Enrico, Aloisi Maria Stella, Arici Claudio, Pezzotti Patrizio, Serraino Diego, Balzano Roberta, Vigevani Gianmarco, Alberici Francesco, Ursitti Maria, D???Alessandro Margherita, Monforte Antonella d???Arminio, Ippolito Giuseppe, Delayed Presentation and Late Testing for HIV: Demographic and Behavioral Risk Factors in a Multicenter Study in Italy : , 10.1097/00126334-200408010-00009
  25. Ioannidis John P. A., Bassett Roland, Hughes Michael D., Volberding Paul A., Sacks Henry S., Lau Joseph, Predictors and Impact of Patients Lost to Follow-Up in a Long-Term Randomized Trial of Immediate Versus Deferred Antiretroviral Treatment : , 10.1097/00042560-199709010-00004
  26. Nacher M, El GM, Vaz T, Nasser V, Randrianjohany A, Alvarez F, Sobesky M, Magnien C, Couppie P: Risk factors for follow-up interruption of HIV patients in French Guiana. Am J Trop Med Hyg. 2006, 74: 915-917.
  27. LANOY E, MARYKRAUSE M, TATTEVIN P, DRAYSPIRA R, DUVIVIER C, FISCHER P, OBADIA Y, LERT F, COSTAGLIOLA D, THECLINICALEPIDEMIOLOGYGROUPO, Predictors identified for losses to follow-up among HIV-seropositive patients, 10.1016/j.jclinepi.2005.11.024
  28. Lebouche B, Yazdanpanah Y, Gerard Y, Sissoko D, Ajana F, Alcaraz I, Boitte P, Cadore B, Mouton Y, Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998, 10.1111/j.1468-1293.2006.00357.x
  29. Couturier Elisabeth, Schwoebel Valérie, Michon Christophe, Hubert Jean-Baptiste, Delmas Marie-Christine, Morlat Philippe, Boué François, Simonpoli Anne-Marie, Dabis François, Brunet Jean-Baptiste, Determinants of delayed diagnosis of HIV infection in France, 1993–1995 : , 10.1097/00002030-199807000-00016
  30. Perez-Alvarez L, Villahermosa ML, Cuevas MT, Delgado E, Manjon N, Vazquez de PE, Medrano L, Contreras G, Thomson MM, Colomo C, Taboada JA: Single- and multidrug resistance mutations to reverse transcriptase and protease inhibitors: human immunodeficiency virus type 1-infected patients from two geographical areas in Spain. Spanish Groups for Antiretroviral Resistance Studies. J Hum Virol. 2000, 3: 150-156.
  31. Wortley Pascale M., Chu Susan Y., Diaz Theresa, Ward John W., Doyle Brian, Davidson Arthur J., Checko Patricia J., Herr Mary, Conti Lisa, Fann Alan S., Sorvillo Frank, Mokotoff Eve, Levy Anna, Hermann Pat, Norris-Walczak Elizabeth, HIV testing patterns: where, why, and when were persons with AIDS tested for HIV? : , 10.1097/00002030-199509050-00011
  32. Poznansky M. C, Coker R., Skinner C., Hill A., Bailey S., Whitaker L., Renton A., Weber J., HIV positive patients first presenting with an AIDS defining illness: characteristics and survival, 10.1136/bmj.311.6998.156
  33. Girardi Enrico, Sampaolesi Alessandro, Gentile Marco, Nurra Giuseppina, Ippolito Giuseppe, Increasing Proportion of Late Diagnosis of HIV Infection Among Patients With AIDS in Italy Following Introduction of Combination Antiretroviral Therapy : , 10.1097/00126334-200009010-00010
  34. McDonald Ann M., Li Yueming, Dore Gregory J., Ree Hugo, Kaldor John M., Late HIV presentation among AIDS cases in Australia, 1992-2001, 10.1111/j.1467-842x.2003.tb00607.x
  35. Klein Daniel, Hurley Leo B., Merrill Deanna, Quesenberry Charles P., Review of Medical Encounters in the 5 Years Before a Diagnosis of HIV-1 Infection: Implications for Early Detection : , 10.1097/00126334-200302010-00005
  36. Samet Jeffrey H., Freedberg Kenneth A., Savetsky Jacqueline B., Sullivan Lisa M., Stein Michael D., Understanding delay to medical care for HIV infection: the long-term non-presenter : , 10.1097/00002030-200101050-00012
  37. Wasserfallen Jean-Blaise, Hyjazi Alexandre, Cavassini Matthias, Comparison of HIV-infected patients’ characteristics, healthcare resources use and cost between native and migrant patients, 10.1007/s00038-008-7043-z
  38. Burns F. M., Imrie J. Y., Nazroo J., Johnson A. M., Fenton K. A., Why the(y) wait? Key informant understandings of factors contributing to late presentation and poor utilization of HIV health and social care services by African migrants in Britain, 10.1080/09540120600908440
  39. Messiah A., Sociodemographic and Behavioral Characteristics Associated with Timeliness and Retention in a 6-Month Follow-up Study of High-Risk Injection Drug Users, 10.1093/aje/kwg065
  40. Chan Alex C. H., Palepu Anita, Guh Daphne P., Sun Huiying, Schechter Martin T., O'Shaughnessy Michael V., Anis Aslam H., HIV-Positive Injection Drug Users Who Leave the Hospital Against Medical Advice : The Mitigating Role of Methadone and Social Support, 10.1097/00126334-200401010-00008
  41. Deyo Richard A., Inui Thomas S., Dropouts and Broken Appointments : A Literature Review and Agenda for Future Research, 10.1097/00005650-198011000-00006
  42. Ndiaye B, Ould-Kaci K, Salleron J, Bataille P, Bonnevie F, Choisy P, Cochonat K, Fontier C, Guerroumi H, Ajana F, Chaud P, Yazdanpanah Y: Incidence rate and risk factors for loss to follow-up in HIV-infected patients from five French clinical centres in Northern France - January 1997 to December 2006. Antivir Ther. 2009, 14 (4): 567-75.
  43. Friedland GH, Williams A: Attaining higher goals in HIV treatment: the central importance of adherence. AIDS. 1999, 13 (Suppl 1): S61-S72.
  44. Dépistage de l'infection par le VIH. Nouvelles recommandations de la HAS. [ ]
  45. Yazdanpanah Yazdan, Sloan Caroline E., Charlois-Ou Cécile, Le Vu Stéphane, Semaille Caroline, Costagliola Dominique, Pillonel Josiane, Poullié Anne-Isabelle, Scemama Olivier, Deuffic-Burban Sylvie, Losina Elena, Walensky Rochelle P., Freedberg Kenneth A., Paltiel A. David, Routine HIV Screening in France: Clinical Impact and Cost-Effectiveness, 10.1371/journal.pone.0013132
  46. Delpierre C., Cuzin L., Lert F., Routine testing to reduce late HIV diagnosis in France, 10.1136/bmj.39225.458218.94
  47. Delpierre Cyrille, Cuzin Lise, Lauwers-Cances Valérie, Marchou Bruno, Lang Thierry, High-Risk Groups for Late Diagnosis of HIV Infection: A Need for Rethinking Testing Policy in the General Population, 10.1089/apc.2006.20.838